PlexusDx's Precision Peptide Genetic Test ($99 add-on) maps your FTO, MC4R, GLP1R, and GIPR variants across 14 metabolic pathways, revealing how your appetite signaling and fat storage genes interact with post-surgical bile acid changesenabling truly personalized semaglutide dosing
Macone AB, Caruso BK, Leahy RG, Donatelli J, Weir S, Draper MP, et al
Using the SCCA2 ELISA test allows you to: Quantify the actual state of the disease objectively Motivate patients and parents to continue proper treatment Provide reliable data to support clinical decisions Lets improve diagnosis and treatment outcomes together
Shao, B
GLP-1 RAs are hypothesized to confer a cancer-risk benefit partly through anti-inflammatory mechanisms, in addition to their established effects on glycemic control and weight reduction
Specifically in patients with T2DM, mean weight loss with GLP-1 RAs typically ranges from 2 to 7 kg across randomized controlled trials, with greater reductions (up to 15 kg with semaglutide) reported in obesity trials